Clover Health Investments, Corp.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Andrew Toy
- Full Time Employees
- 724
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- Address
- 1209 Orange Street Wilmington DE United States of America 37067
- IPO Date
- Jun 12, 2020
- CIK
- 0001801170
- Website
- cloverhealth.com
- Similar Companies
- Business
- Clover Health Investments, Corp. is a healthcare technology company primarily focused on providing Medicare Advantage insurance plans combined with a proprietary software platform designed to improve clinical outcomes and reduce healthcare costs. The company offers a comprehensive suite of insurance products including Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans targeting Medicare-eligible seniors, with a differentiated focus on wide-network, high-choice PPO plans. Clover Health’s flagship software, Clover Assistant, integrates patient data from over 100 sources using artificial intelligence, natural language processing, and machine learning to empower physicians in proactive chronic disease management and enhance quality of care. The company also extends its technology through its subsidiary Counterpart Health, which licenses its AI-driven platform to third-party healthcare providers. Founded in 2014 and headquartered in Wilmington, Delaware, Clover Health operates Medicare Advantage plans in five states, serving over 100,000 members with coverage spanning 203 counties, including plans with $0 to low monthly premiums and additional benefits such as dental, vision, hearing, and over-the-counter drug coverage. The company’s insurance segment generates revenues through Medicare contracts, while its technology platform aims to improve physician efficiency and patient health outcomes. Clover Health stands out with its AI-powered HEDIS flywheel, which has driven it to become the top-performing PPO plan by clinical quality measures. Recent major developments include the launch of the 2026 Medicare Advantage portfolio with a stable or improved plan lineup accessible to 5.2 million Medicare beneficiaries, emphasizing broader PPO coverage and AI-supported care through Clover Assistant. The company reported significant growth in 2025, with Medicare Advantage membership up 35% year-over-year, total revenues increasing 50%, and a move toward profitability with adjusted EBITDA improving notably. Clover Health also raised its full-year 2025 guidance, highlighting expectations for continued membership growth, expanded adjusted EBITDA profitability through 2027, and a favorable regulatory environment in Medicare Advantage. Additionally, the company made its AI platform available to third-party partners on October 14, 2025, advancing its strategic shift toward scaling technology beyond insurance offerings. Clover Health went public in early 2021 through a merger with Social Capital Hedosophia Holdings Corp. III and continues to focus on healthcare equity for seniors, extending access to affordable, comprehensive Medicare plans. It combines health insurance with advanced data-driven technology solutions to enhance care quality and reduce medical costs, positioning itself as both a health insurer and a healthcare technology innovator within the Medicare Advantage market. The company is committed to expanding its technology-enabled healthcare services and participating in the evolving value-based care landscape. This profile reflects Clover Health Investments Corp.'s current operations, product offerings, and strategic developments as of late 2025.
Clover Health says employee accounts accessed in cyber incident
Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026
Clinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Up
Clover Health's CEO Sold Company Shares Worth $1.7 Million. Here's What That Means for Investors.
A Clover Health Director Sold Over 67,000 Company Shares. Here's a Closer Look at the Transaction.
Clover Health Stock Extends Gains After Court Forces CMS to Upgrade Medicare Star Rating
A Clover Health Insider Sold Over 220,000 Company Shares. What Does That Mean for Investors?
Clover Health Investments, Corp. (CLOV) Q1 2026 Earnings Call Transcript
Clover Health Q1 Earnings Meet Estimates, Sales Beat, Membership Rises
Clover Health Investments, Corp. (CLOV) Meets Q1 Earnings Estimates
Clover Health Reports First Quarter 2026 Results
Butterfly Network, Inc. (BFLY) Reports Q1 Loss, Beats Revenue Estimates
Here's Why You Should Retain Clover Stock in Your Portfolio for Now
Clover Health to Report First Quarter 2026 Financial Results on May 6, 2026
Clover Health Empowers Members to Take Charge of Their Health Data Through HealthEx Partnership
Clover Health Investments Target of Unusually Large Options Trading (NASDAQ:CLOV)
Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026
Clover Health Investments, Corp. (NASDAQ:CLOV) Receives $2.90 Consensus PT from Analysts
Primary Care Physician Use of Counterpart Assistant Associated with 18%–22% Fewer Flu-Related Acute Care Events Among COPD and CHF Patients
Clover Health: Strong Growth, Improving Margins, And A Mispriced Stock